Antibody specific for the glycophorin A complex mediates intravenous immune globulin-resistant anemia in a murine model

Transfusion

Volumn 54, Issue 3, 2014, Pages 655-664

  Chen, Xi ^a   Ghaffar, Hasan ^a   Jen, Chao Ching ^a   Lazarus, Alan H ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; FC RECEPTOR; GLYCOPHORIN A; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; FEMALE; MOUSE; MOUSE MODEL; NONHUMAN; SPLENECTOMY; THERAPY EFFECT;

ANEMIA; ANIMALS; ANTIBODIES; FEMALE; GLYCOPHORIN; IMMUNOGLOBULINS, INTRAVENOUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 84896048008     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12300     Document Type: Article

References (38)

1. Petz L, Garratty G,. Immune hemolytic anemias. 2nd ed. Philadelphia (PA): Churchill Livingstone; 2004.
2. Brain MC, Prevost JM, Pihl CE, Brown CB,. Glycophorin A-mediated haemolysis of normal human erythrocytes: evidence for antigen aggregation in the pathogenesis of immune haemolysis. Br J Haematol 2002; 118: 899-908.
3. Brain MC, Ruether B, Valentine K, Brown C, ter Keurs H,. Life-threatening hemolytic anemia due to an autoanti-pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination. Transfusion 2010; 50: 292-301.
4. Brain MC, Pihl C, Robertson L, Brown CB,. Evidence for a mechanosensitive calcium influx into red cells. Blood Cells Mol Dis 2004; 32: 349-352.
5. Cartron JP, Rahuel C,. Human erythrocyte glycophorins: protein and gene structure analyses. Transfus Med Rev 1992; 6: 63-92.
6. Chasis JA, Mohandas N,. Red blood cell glycophorins. Blood 1992; 80: 1869-1879.
7. Auffray I, Marfatia S, de Jong K, Lee G, Huang CH, Paszty C, Tanner MJ, Mohandas N, Chasis JA,. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood 2001; 97: 2872-2878.
8. Tanner MJ, Anstee DJ,. The membrane change in en(a-) human erythrocytes. absence of the major erythrocyte sialoglycoprotein. Biochem J 1976; 153: 271-277.
9. Ott C, Lardi E, Schulzki T, Reinhart WH,. The influence of erythrocyte aggregation on induced platelet aggregation. Clin Hemorheol Microcirc 2010; 45: 375-382.
10. Knowles DW, Chasis JA, Evans EA, Mohandas N,. Cooperative action between band 3 and glycophorin A in human erythrocytes: immobilization of band 3 induced by antibodies to glycophorin A. Biophys J 1994; 66: 1726-1732.
11. Chasis JA, Mohandas N, Shohet SB,. Erythrocyte membrane rigidity induced by glycophorin A-ligand interaction. evidence for a ligand-induced association between glycophorin A and skeletal proteins. J Clin Invest 1985; 75: 1919-1926.
12. Safeukui I, Buffet PA, Deplaine G, Perrot S, Brousse V, Ndour A, Nguyen M, Mercereau-Puijalon O, David PH, Milon G, Mohandas N,. Quantitative assessment of sensing and sequestration of spherocytic erythrocytes by the human spleen. Blood 2012; 120: 424-430.
13. Garratty G,. A new mechanism for immune destruction of red blood cells? Transfusion 2010; 50: 274-277.
14. Lechner K, Jager U,. How I treat autoimmune hemolytic anemias in adults. Blood 2010; 116: 1831-1838.
15. Flores G, Cunningham-Rundles C, Newland AC, Bussel JB,. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol 1993; 44: 237-242.
16. Webster ML, Sayeh E, Crow M, Chen P, Nieswandt B, Freedman J, Ni H,. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies. Blood 2006; 108: 943-946.
17. Song S, Crow AR, Freedman J, Lazarus AH,. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG. Blood 2003; 101: 3708-3713.
18. Song S, Crow AR, Siragam V, Freedman J, Lazarus AH,. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg. Blood 2005; 105: 1546-1548.
19. Deng R, Balthasar JP,. Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia. Blood 2007; 109: 2470-2476.
20. Ikuta K, Kina T, MacNeil I, Uchida N, Peault B, Chien YH, Weissman IL,. A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell 1990; 62: 863-874.
21. Crow AR, Suppa SJ, Chen X, Mott PJ, Lazarus AH,. The neonatal fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia. Blood 2011; 118: 6403-6406.
22. Chadebech P, Michel M, Janvier D, Yamada K, Copie-Bergman C, Bodivit G, Bensussan A, Fournie JJ, Godeau B, Bierling P, Izui S, Noizat-Pirenne F,. IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and FcalphaRI. Blood 2010; 116: 4141-4147.
23. Pottier Y, Pierard I, Barclay A, Masson PL, Coutelier JP,. The mode of action of treatment by IgG of haemolytic anaemia induced by an anti-erythrocyte monoclonal antibody. Clin Exp Immunol 1996; 106: 103-107.
24. Azeredo da Silveira S, Kikuchi S, Fossati-Jimack L, Moll T, Saito T, Verbeek JS, Botto M, Walport MJ, Carroll M, Izui S,. Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody. J Exp Med 2002; 195: 665-672.
25. Anderson D, Ali K, Blanchette V, Brouwers M, Couban S, Radmoor P, Huebsch L, Hume H, McLeod A, Meyer R, Moltzan C, Nahirniak S, Nantel S, Pineo G, Rock G,. Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfus Med Rev 2007; 21 (2 Suppl 1): S9-56.
26. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, Gebhard F, Younger JG, Drouin SM, Wetsel RA, Ward PA,. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006; 12: 682-687.
27. van den Berg CW, Hofhuis FM, Rademaker PM, van Dijk H,. Induction of active immunological hypo/non-responsiveness to C5 in adult C5-deficient DBA/2 mice. Immunology 1991; 74: 380-385.
28. Kalli KR, Fearon DT,. Binding of C3b and C4b by the CR1-like site in murine CR1. J Immunol 1994; 152: 2899-2903.
29. Berentsen S, Tjonnfjord GE,. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Rev 2012; 26: 107-115.
30. Hara H, Ogawa M,. Erthropoietic precursors in mice with phenylhydrazine-induced anemia. Am J Hematol 1976; 1: 453-458.
31. Spivak JL, Toretti D, Dickerman HW,. Effect of phenylhydrazine-induced hemolytic anemia on nuclear RNA polymerase activity of the mouse spleen. Blood 1973; 42: 257-266.
32. Tan JK, O'Neill HC,. Investigation of murine spleen as a niche for hematopoiesis. Transplantation 2010; 89: 140-145.
33. Brodsky I, Dennis LH, Kahn SB, Brady LW,. Normal mouse erythropoiesis. I. The role of the spleen in mouse erythropoiesis. Cancer Res 1966; 26: 198-201.
34. Waterbury L, Parnes H, Katz RS,. Fatal warm antibody autoimmune hemolysis with marked erythrocyte autoagglutination and liver necrosis. South Med J 1986; 79: 646-647.
35. Shirey RS, Kickler TS, Bell W, Little B, Smith B, Ness PM,. Fatal immune hemolytic anemia and hepatic failure associated with a warm-reacting IgM autoantibody. Vox Sang 1987; 52: 219-222.
36. Garratty G, Arndt P, Domen R, Clarke A, Sutphen-Shaw D, Clear J, Groncy P,. Severe autoimmune hemolytic anemia associated with IgM warm autoantibodies directed against determinants on or associated with glycophorin A. Vox Sang 1997; 72: 124-130.
37. Jordan MB, van Rooijen N, Izui S, Kappler J, Marrack P,. Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. Blood 2003; 101: 594-601.
38. Liepkalns JS, Hod EA, Stowell SR, Cadwell CM, Spitalnik SL, Zimring JC,. Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor fcgamma receptors in a murine model. Transfusion 2012; 52: 2631-2645.